Show
Sort by
-
Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
-
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials
-
Prognostic factors in patients with intermediate and high risk stage TA T1 papillary carcinoma of the bladder treated with maintenance epirubicin or maintenance bacillus Calmette-Guerin. Results of eortc gu group study 30911
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: A meta-analysis of published results of randomized clinical trials
-
Maintenance bacillus Calmette-Guerin for TaT1 bladder tumors is not associated with increased toxicity: results from a European organisation for research and treatment of cancer genito-urinary group phase III trial.
-
Maintenance Bacillus Calmette-Guerin for Ta, T1 bladder cancer is not associated with increased toxicity. Results from an European organization for research and treatment of cancer genitourinary group phase III trial.
-
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies.